---
title: 'Software Daily Summary: What Happened on October 7, 2026'
headline: Gilead extends Cognizant DevOps deal for five years
description: A Genentech team trying to automate an assay found that an AI system
  struggled with viscous liquid.
url: https://thebench.bio/news/software/2026-10-07
topic: software
date: '2026-10-07'
covers:
- '2026-10-07'
date_published: '2026-10-07T12:03:02Z'
date_modified: '2026-10-07T12:03:02Z'
sources: 2
publisher: The Bench (thebench.bio)
---

# Software Daily Summary: What Happened on October 7, 2026

**Gilead extends Cognizant DevOps deal for five years**

A Genentech team trying to automate an assay found that an AI system struggled with viscous liquid.

## Today in brief

Gilead extended its Cognizant agreement for five years, adding support for selected AI projects to its DevOps work. [1] During a Genentech effort to automate an assay, a person spotted an AI system’s pipetting error with a viscous liquid. [2]

## The day in numbers

- **5 years**: Term of Gilead’s extended DevOps agreement with Cognizant. [1]
- **More than a decade**: Length of Gilead and Cognizant’s collaboration. [1]

## Also published

- [Are Insights leaders seeing real commercial value from AI adoption yet?](<https://pharmaphorum.com/sales-marketing/are-insights-leaders-seeing-real-commercial-value-ai-adoption-yet>), pharmaphorum

## Sources

1. [Gilead Sciences signs five-year DevOps agreement with Cognizant](<https://www.pharmaceutical-technology.com/news/gilead-sciences-cognizant-devops/>), Pharmaceutical Technology, 2026-10-07
2. [PhD in Theory, Undergrad in Practice](<https://brieflybio.substack.com/p/phd-in-theory-undergrad-in-practice>), Briefly Bio, 2026-10-07

---

The Bench wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://www.pharmaceutical-technology.com/news/gilead-sciences-cognizant-devops/>
[2]: <https://brieflybio.substack.com/p/phd-in-theory-undergrad-in-practice>
